Forward P/S Multiple: Premier, Inc. (PINC)

Corporate emblem and logo of Premier Health (PINC)

The investment attractiveness of Premier, Inc. (PINC) is based on the implementation of sustainable supply chains and energy-efficient equipment. This forward price-to-sales valuation chart visualizes this trend, where 0.00 serves as the final level marker. Stability is ensured by the powerful network effect of the largest GPO ecosystem and successful adaptation to geopolitical risks through the support of US medical product manufacturers.

Premier - PINC Market Cap to Future Revenue Ratio (period 07/04/2022 - 10/17/2026)

Comprehensive metric breakdowns and analytics for Premier Health (PINC)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Comprehensive company analysis:PINC (Premier)
Manufactured products of Premier Health

This indicator assesses the market value of an asset relative to expected sales volumes, making it possible to determine the degree of business undervaluation or the risk of capitalization stagnation. The implementation of AI algorithms into the healthcare logistics of Premier, Inc. (PINC) should drive revenue growth; therefore, an analysis of the forward revenue multiple will help determine if this technological expansion is currently priced into the stock.

Competitor analysis for Premier, Inc.

Price-to-Projected Revenue Ratio HCA Healthcare HCA|THC - Forward Price-to-Revenue Multiple|Fresenius Medical Care Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio Solventum Health SOLV|EHC: Forward P/S Multiple|Market Cap to Future Revenue Ratio Universal Health Services, Inc. (UHS)|Price-to-Projected Revenue Ratio DaVita|RDNT: Forward Price to Sales|Forward Price-to-Revenue Multiple OPCH (Option Care Health Inc)|SGRY (Surgery Partners Group) - Forward Price to Sales|Forward P/S Multiple EYE (National Vision Holdings)|Market Cap to Expected Sales Ratio progyny.com (PGNY)|ARDT - Price-to-Projected Revenue Ratio|SEM (Select Medical Corporation) - Market Cap to Projected Revenue|ASTH: Forward P/S Multiple|Forward Price-to-Revenue Multiple MEDNAX|Forward Price-to-Revenue Multiple USPH|pennantgroup.com (PNTG) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Organogenesis (ORGO)|NUTX: Future Price to Revenue|Forward P/S Multiple AUNA (Auna Health)|Market Cap to Expected Sales Ratio SBC Medical Group Holdings (SBC)|EOLS - Price-to-Projected Revenue Ratio|CYH (chs.net) - Market Cap to Projected Revenue|SKIN: Forward P/S Multiple|Forward Price-to-Revenue Multiple MediWound|Forward Price-to-Revenue Multiple BTMD|JYNT (The Joint) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio DocGo Inc. (DCGO)|PIII (p3hp.org) - Forward Price to Sales|Forward P/S Multiple GANX (Gain Therapeutics)|EUDA Health Holdings (EUDA) - Market Cap to Future Revenue Ratio|Basel Medical Group Limited - Forward P/S Multiple|CLGN - Forward P/S Multiple|CUPR (Cuprina Holdings (Cayman) Ltd) - Forward Price-to-Revenue Multiple|CCM: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio American Shared Hospital Services|Forward Price-to-Revenue Multiple MEDIROM Healthcare Group Inc. (MRM)|Forward P/S Multiple ALBT|DHAI - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Longevity Health Holdings XAGE|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Inc. - Price to Expected Revenue Ratio|Kindly MD Corp (KDLY) - Price-to-Projected Revenue Ratio|Future Price to Revenue MODV (ModivCare Corp)|Price-to-Projected Revenue Ratio Novo Integrated Sciences|SSY: Forward Price to Sales|Forward P/S Multiple BACK